← News
Aug 31, 2026 Psychedelics
New on Altitude: Ibogaine's Flagship Drug Hit a Cardiac Signal and a Lawsuit
Ibogaine's original patents belong to Howard Lotsof, who discovered its anti-addictive effect on himself in 1962 and patented it in 1985 — all long expired. We mapped who holds the 53 patents filed since, and found that DemeRx's original opioid-use-disorder program stalled over a cardiac safety signal and ended in litigation with atai, while a different DemeRx drug, for a different disease, became the first ibogaine-class compound cleared for a US trial. Read it here.
Read at Altitude